Bleeding index after the first course of endoscopic treatment for esophageal varices in liver cirrhotic patients with and without hepatocellular carcinoma

Hepato-Gastroenterology

Volumn 54, Issue 79, 2007, Pages 2049-2054

  Kogo, Mari ^a   Sato, Naka ^a   Yoneyama, Keiichiro ^a   Imawari, Michio ^a   Kiuchi, Yuji ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Bleeding; Endoscopic injection sclerotherapy; Endoscopic variceal ligation; Esophageal varices; Hepatocellular carcinoma

Indexed keywords

ALPHA FETOPROTEIN; HEMOGLOBIN; LACTATE DEHYDROGENASE; MONOETHANOLAMINE OLEATE; POLIDOCANOL;

ADULT; AGED; ARTICLE; BLEEDING; CONTROLLED STUDY; ENDOSCOPIC SCLEROTHERAPY; ENDOSCOPIC THERAPY; ESOPHAGUS VARICES; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; CARCINOMA, HEPATOCELLULAR; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES;

EID: 37749042983     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Gentilini P, Laffi G, La Villa G, et al: Long course and prognostic factors of virus-induced cirrhosis of the liver. Am J Gastroenterol 1997; 92:66-72.
2. Salerno F, Borroni G, Moser P, et al: Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation. A prospective multicenter Italian study. AISF Group for the Study of Liver Transplantation. Associazione Italiana per lo Studio del Fegato. J Hepatol 1996; 25:474-480.
3. Grace ND: Prevention of initial variceal hemorrhage. Gastroenterol Clin North Am 1992; 21:149-161.
4. de Dombal FT, Clarke JR, Clamp SE, et al: Prognostic factors in upper G.I. bleeding. Endoscopy 1986; (Suppl 2):6-10.
5. Laine L, Cook D: Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis. Ann Intern Med 1995; 123:280-287.
6. Singh P, Pooran N, Indaram A, et al: Combined ligation and sclerotherapy versus ligation alone for secondary prophylaxis of esophageal variceal bleeding: a meta-analysis. Am J Gastroenterol 2002; 97:623-629.
7. Yoshida H, Tajiri T, Mamada Y, et al: Comparison of characteristics of recurrent esophageal varices after endoscopic ligation versus endoscopic ligation plus sclerotherapy. Hepatogastroenterology 2004; 51:457-461.
8. The Liver Cancer Study Group of Japan: General rules for the clinical and pathological study of primary liver cancer (Second English Edition). Tokyo: Kanehara & Co., Ltd., 2003.
9. Sherlock S, Dooly J: Hepatic encephalopathy. In: Disease of the Liver and Biliary System. 6th Edition. London: Blackwell Science, 1981; pp. 91-106
10. Pugh RN, Murray-Lyon IM, Dawson JL, et al: Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60:646-649.
11. Japanese Research Society for Portal Hypertension: The general rules for recording endoscoric findings on esophageal varices. Jpn J Surg 1980; 10:84-87.
12. Hashizume M, Kitano S, Koyanagi N, et al: Endoscopic injection sclerotherapy for 1,000 patients with esophageal varices: a nine-year prospective study. Hepatology 1992; 15:69-75.
13. Ishida M, Masuyama H: A prognostic evaluation of endoscopic intravariceal injection sclerotherapy for esophageal varices. Gastroenterol Jpn 1989; 24:347-356.
14. Nakashima T, Kojiro M: Pathologic characteristics of hepatocellular carcinoma. Semin Liver Dis 1986; 6:259-266.
15. Nguyen MH, Garcia RT, Simpson PW, et al: Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis. Hepatology 2002; 36:410-417.
16. The Cancer of the Liver Italian Program (CLIP) Investigators: Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 2000; 314:840-845.
17. Hanazaki K, Kajikawa S, Koide N, et al: Prognostic factors after hepatic resection for hepatocellular carcinoma with hepatitis C viral infection: univariate and multivariate analysis. Am J Gastroenterol 2001; 96:1243-1250.
18. Kokawa H, Shijo H, Kubara K, et al: Long-term risk factors for bleeding after first course of endoscoric injection sclerotherapy: a univariate and multivariate analysis. Am J Gastroenterol 1993; 88:1206-1211.
19. Senjyu S, Nishida H, Sakamoto M, et al: Endoscopic color Doppler ultrasonographic evaluation of recurrent esophagogastric varices following endoscopic injection sclerotherapy. Hepatol Res 2003; 26:174-180.
20. de Franchis R: Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices: A prospective multicenter study. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. N Engl J Med 1988; 319:983-989.
21. Sakaki M, Iwao T, Oho K, et al: Prognostic factors in cirrhotic patients receiving long-term sclerotherapy for the first bleeding from oesophageal varices. Eur J Gastroenterol Hepatol 1998; 10:21-26.